GSK-3β, a principal enzyme responsible for pathological phosphorylation of tau [111], is upregulated in AD [112], (Figure 2, label 13), with its activity correlating with the amount of NFTs in AD brains [113]. This evidence concerns the gene MAPT and Alzheimer disease.